CFGS
PFE icon

Concourse Financial Group Securities’s Pfizer PFE Stock Holding History

Concourse Financial Group Securities’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-61,299
Closed -$1.59M – 1494
2024
Q4 		$1.59M Buy
61,299
+7,098
+13% +$193K 0.09% 230
2024
Q3 		$1.57M Buy
54,201
+7,366
+16% +$215K 0.09% 212
2024
Q2 		$1.31M Buy
46,835
+369
+0.8% +$10.2K 0.08% 230
2024
Q1 		$1.29M Buy
46,466
+4,803
+12% +$133K 0.08% 240
2023
Q4 		$1.2M Sell
41,663
-15,596
-27% -$471K 0.09% 243
2023
Q3 		$1.9M Sell
57,259
-93
-0.2% -$3.29K 0.15% 149
2023
Q2 		$2.1M Buy
57,352
+875
+2% +$34.1K 0.16% 130
2023
Q1 		$2.3M Sell
56,477
-1,536
-3% -$66.3K 0.18% 123
2022
Q4 		$2.97M Sell
58,013
-3,055
-5% -$146K 0.24% 98
2022
Q3 		$2.67M Buy
61,068
+6,654
+12% +$323K 0.25% 96
2022
Q2 		$2.85M Sell
54,414
-609
-1% -$31K 0.24% 96
2022
Q1 		$2.85M Sell
55,023
-17,471
-24% -$906K 0.21% 106
2021
Q4 		$4.28M Sell
72,494
-16,488
-19% -$817K 0.24% 88
2021
Q3 		$3.83M Sell
88,982
-2,449
-3% -$108K 0.23% 95
2021
Q2 		$3.58M Buy
91,431
+4,762
+5% +$185K 0.22% 95
2021
Q1 		$3.14M Sell
86,669
-731
-0.8% -$26K 0.22% 100
2020
Q4 		$3.22M Buy
87,400
+3,554
+4% +$130K 0.24% 90
2020
Q3 		$2.92M Buy
83,846
+10,920
+15% +$383K 0.25% 87
2020
Q2 		$2.26M Buy
72,926
+8,021
+12% +$272K 0.22% 94
2020
Q1 		$2.01M Buy
64,905
+6,463
+11% +$220K 0.22% 100
2019
Q4 		$2.17M Buy
58,442
+29,512
+102% +$1.05M 0.22% 99
2019
Q3 		$986K Sell
28,930
-27,704
-49% -$1.01M 0.25% 78
2019
Q2 		$2.33M Buy
56,634
+14,512
+34% +$576K 0.24% 80
2019
Q1 		$1.7M Sell
42,122
-17,038
-29% -$682K 0.17% 108
2018
Q4 		$2.45M Buy
59,160
+45,799
+343% +$1.9M 0.29% 70
2018
Q3 		$559K Buy
+13,361
New +$514K 0.16% 137

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Concourse Financial Group Securities's PFE Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Pfizer (PFE) in Q1 2025, closing a stake of 61,299 shares — an estimated $1.59M sold.

Concourse Financial Group Securities first reported a position in PFE in Q3 2018 and held it in 26 quarters. The position peaked at $4.28M in Q4 2021. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 61,299 Pfizer shares in Q1 2025, an estimated $1.59M.
  • Concourse Financial Group Securities first reported a position in Pfizer in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's Pfizer position peaked at $4.28M in Q4 2021.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.